Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery

Gene Therapy

Volumn 8, Issue 2, 2001, Pages 139-148

  Tanaka, M ^a   Fraizer, G C ^a   De La Cerda, J ^a   Cristiano, R J ^a   Liebert, M ^b   Grossman, H B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

Adenovirus PLL DNA complexes; Bladder cancer; Bystander effect; Connexin 26; HSVtk GCV gene therapy

Indexed keywords

BETA GALACTOSIDASE; CONNEXIN 26; DNA; GANCICLOVIR; GAP JUNCTION PROTEIN; PLASMID VECTOR; POLYLYSINE; THYMIDINE KINASE; VIRUS ENZYME;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER THERAPY; CELL COMMUNICATION; CLINICAL OBSERVATION; CONJUGATE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXICITY; GAP JUNCTION; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL COMMUNICATION; CELL SURVIVAL; CONNEXINS; GANCICLOVIR; GAP JUNCTIONS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; POLYLYSINE; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HERPES; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 0035134748     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301367     Document Type: Article

References (52)

1. Superficial bladder cancer: Decreasing the risk of recurrence
2. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients
3. The treated natural history of high risk superficial bladder cancer: 15-year outcome
4. Connexin expression and intercellular communication in two- and three-dimensional in vitro cultures of human bladder carcinoma
5. Gap junctions: New tools, new answers, new questions
6. Gap junctions in the brain: Where, what type, how many and why?
7. Expression of gap junction genes in astrocytes and C6 glioma cells
8. Transcriptional down-regulation of gap junction proteins blocks junctional communication in mammary cell lines
9. Decreased connexin expression and intercellular communication in human bladder cancer cells
10. Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo
11. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein
12. Negative growth control of HeLa cells by connexin gene: Connexin species specificity
13. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary cells and restore differentiation potential
14. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
15. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene
16. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
17. Thymidine kinase-mediated killing of rat brain tumors
18. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
19. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
20. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells
21. The bystander effect by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
22. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy
23. Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy
24. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma
25. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation
26. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
27. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy
28. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy
29. Gene therapy for cancer: What have we done and where are we going?
30. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
31. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer
32. Vectors in cancer therapy: How will they deliver?
33. In situ use of suicide genes for cancer therapy
34. Immune system in suicide gene therapy
35. Generation of an anti-tumor immune response in a non-immunogenic tumor: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th-1-like profile of intratumoral cytokine expression
36. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice
37. A 'distant' bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
38. Transfection of rhabdomyosarcoma cells with connexin 43 induces myogenic differentiation
39. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype
40. Role of connexin (gap junction) genes in cell growth control and carcinogenesis
41. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues
42. Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex
43. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex
44. Efficient gene transfer into normal human skeletal cells using recombinant adenovirus and conjugated adenovirus-DNA complexes
45. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex
46. Histochemical staining following LacZ gene transfer underestimates transfection efficiency
47. Connexin 43-enhanced suicide gene therapy using herpesviral vectors
48. Improved growth of human urothelial carcinoma cell cultures
49. Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene
50. Gelsolin: A candidate for suppressor of human bladder cancer
51. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication